AbbVie-Apogee deal on radar for US healthcare stocks next week
Healthcare stocks in the U.S. could move Monday after a report said AbbVie is nearing a $10.9 billion cash takeover of Apogee Therapeutics. That price would be about 60% over where Apogee ended Thursday. Neither company has confirmed a deal. The report came out Friday as U.S. exchanges were closed for Juneteenth, so investors got no chance to trade during normal hours. Markets stay closed Sunday and won’t reopen until 9:30 a.m. EDT on June 22. AbbVie and Apogee are expected to be in focus when the sector opens.